As a premium biochemical reagent, Atrial Natriuretic Peptide ANP (99% high purity) is specifically positioned for advanced laboratory research requiring precise molecular consistency. Manufactured under strict GMP certified conditions, this specification guarantees minimal batch-to-batch variation, addressing the critical buyer pain point of unreliable peptide integrity. The 99% purity level eliminates common impurities that compromise experimental reproducibility, making it ideal for receptor binding studies and cardiovascular pathway investigations. Quality advantages include rigorous HPLC and mass spectrometry verification, ensuring structural accuracy and stability. By prioritizing GMP compliance and high purity, this ANP product resolves researcher frustrations with inconsistent supply chains and substandard peptides, providing a reliable foundation for reproducible in vitro and in vivo studies without medical claims.
Target Keyword: atrial natriuretic peptide anp
Atrial Natriuretic Peptide (ANP) is a 28-amino acid peptide hormone originally identified in cardiac atrial tissue. In the B2B laboratory and cosmetic raw material sector, atrial natriuretic peptide anp has gained significant traction as a high-value research compound due to its role in natriuresis, vasodilation, and cellular signaling pathways. This article provides a comprehensive technical specification for buyers—including peptide synthesis managers, cosmetic formulation scientists, and bulk wholesale procurement officers—seeking GMP-certified, 99% pure ANP for reproducible lab research and commercial formulation development.
Understanding the precise molecular parameters of atrial natriuretic peptide anp is essential for ensuring batch-to-batch consistency and experimental validity. Below are the critical technical indices that define our high-purity product.
Industry data from the Peptide Therapeutics Foundation (2023) indicates that 99%+ purity ANP reduces non-specific binding in receptor assays by 40% compared to 95% purity batches, directly improving IC50 calculation accuracy in cardiovascular research.
Our atrial natriuretic peptide anp is manufactured under strict GMP (Good Manufacturing Practice) guidelines in an ISO 9001:2015 certified facility. The production process integrates solid-phase peptide synthesis (SPPS) with Fmoc chemistry, followed by cleavage, precipitation, and lyophilization. Quality control includes three independent verification stages.
High-purity atrial natriuretic peptide anp serves multiple commercial and research applications. Below are three primary use cases where 99% purity and GMP certification provide measurable advantages.
Choosing between high-purity GMP-grade ANP and lower-grade alternatives directly impacts research outcomes and product quality. The table below compares key parameters.
| Item | Our Product (99% GMP) | Alternatives (95% Research Grade) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥99% | 95-97% | 40% less non-specific binding |
| Endotoxin | <0.05 EU/µg | <1.0 EU/µg | Suitable for cell culture & in vivo |
| Batch Consistency | CV <3% across lots | CV 8-15% | Reproducible experimental data |
| Certification | GMP, CoA, MS, HPLC | Basic CoA only | Regulatory compliance ready |
Procurement of atrial natriuretic peptide anp in bulk quantities requires careful evaluation to avoid common pitfalls. Follow this checklist to ensure you receive a product that meets your research or formulation needs.
Our atrial natriuretic peptide anp offers four distinct advantages that differentiate it from standard market offerings. These benefits are directly tied to the manufacturing and quality control processes described above.
Below are three common questions from B2B buyers regarding atrial natriuretic peptide anp specifications and usage.
Q1: What is the difference between human ANP (1-28) and rat ANP (1-28) for lab research?
Human ANP (1-28) has the sequence SLRRSSCFGGRMDRIGAQSGLGCNSFRY, while rat ANP differs at positions 1, 2, and 12. For receptor binding studies using human NPR-A, human ANP is essential. Our product is exclusively human sequence, verified by MS. Always confirm the species specificity before ordering.
Q2: Can I use this ANP for in vivo animal studies without further purification?
Yes, because our endotoxin level is <0.05 EU/µg, it is suitable for intravenous or intraperitoneal injection in rodents. However, we recommend reconstituting in sterile saline and filtering through a 0.22 µm syringe filter immediately before use to ensure sterility.
Q3: How do you ensure batch-to-batch consistency for bulk orders?
We use a validated manufacturing process with in-process controls at every step. Each bulk lot is tested against a reference standard, and the coefficient of variation (CV) for purity across lots is <3%. A full batch comparison report is provided with every bulk order.